(Q74313508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

D M Ignar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J L Andrews

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S M Witherspoon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J D Leray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W C Clay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Kilpatrick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Onori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T Kost

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D L Emerson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

9-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9502073%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006503816792

10 November 2019

exact match

0 references

cites work

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

12 December 2020

Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

1 reference

12 December 2020

Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator

1 reference

12 December 2020

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

1 reference

12 December 2020

A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines

1 reference

12 December 2020

Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers

1 reference

12 December 2020

Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor

1 reference

12 December 2020

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

1 reference

12 December 2020

Binding of single-chain prourokinase to the urokinase receptor of human U937 cells

1 reference

12 December 2020

Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells

1 reference

12 December 2020

Phase separation of integral membrane proteins in Triton X-114 solution

1 reference

12 December 2020

Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.

1 reference

12 December 2020

Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas

1 reference

12 December 2020

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease

1 reference

12 December 2020

Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation

1 reference

12 December 2020

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

12 December 2020

Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse

1 reference

12 December 2020

Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor

1 reference

12 December 2020

Increased cell-surface urokinase in advanced ovarian cancer.

1 reference

12 December 2020

Production and characterization of two new mouse monoclonal antibodies reactive with denatured mouse class II beta chains

1 reference

12 December 2020

Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen

1 reference

12 December 2020

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels

1 reference

12 December 2020

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

1 reference

12 December 2020

Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis

1 reference

12 December 2020

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

12 December 2020

Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B

1 reference

12 December 2020

Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells

1 reference

12 December 2020

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells

1 reference

12 December 2020

Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model

1 reference

12 December 2020

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

12 December 2020

Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator

1 reference

12 December 2020

Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin

1 reference

12 December 2020

The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy

1 reference

12 December 2020

Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity

1 reference

12 December 2020

Characterization of the cellular binding site for the urokinase-type plasminogen activator

1 reference

12 December 2020

Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression.

1 reference

12 December 2020

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

1 reference

12 December 2020

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

12 December 2020

A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.

1 reference

12 December 2020

Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro

1 reference

12 December 2020

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice

1 reference

12 December 2020

Localization of plasminogen activators in human colon cancer by immunoperoxidase staining

1 reference

12 December 2020

Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus

1 reference

12 December 2020

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

12 December 2020

The production and characterization of murine monoclonal antibodies to human Gadd45 raised against a recombinant protein.

1 reference

12 December 2020